Markets & Stocks

Stock quotes, market indicators and the latest market news.

Market Summary Market News Stock Quotes Market Movers

Microbot Medical Inc. - Common Stock (NQ:MBOT)

0.9500 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Price and Volume

Volume	803,002
Open	0.9550
Bid (Size)	0.9400 (5,500)
Ask (Size)	0.9700 (1,100)
Prev. Close	0.9500
Today's Range	0.9450 - 0.9996
52wk Range	0.9300 - 3.030
Shares Outstanding	67,158,044
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel

October 06, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Highlights Growth Strategy

September 25, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Performance

52-Week Range 68.6% below 52-week high

0.9500

0.9352W Low 3.0352W High

1 Week 12.0% below 1-week high

0.931W Low 1.081W High

Microbot Medical Inc. - Common Stock (MBOT) traded between $0.93 and $3.03 over the past 52 weeks and last traded at $0.95, 68.6% below its 52-week high. Over the past week it ranged between $0.93 and $1.08.

Past 12 Months

-8.7%

-34.0%

-45.7%

-59.4%

-55.0%

-66.5%

1W -$0.09

1M -$0.49

3M -$0.80

6M -$1.39

YTD -$1.16

1Y -$1.89

MBOT was -66.5% over the past year, -59.4% over six months, -55.0% year to date, -8.7% in the last week.

12 Months vs Market

MBOT

-66.5%

DIA

+13.0%

SPY

+15.5%

QQQ

+18.3%

IWM

+10.4%

Over the past 12 months MBOT returned -66.5% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 1.21× 3-mo avg

Today 803,002 3-mo avg 661.7K

717.7K

734.0K

661.7K

991.2K

YTD

1.3M

1.6M

MBOT most recently traded 803,002 shares against a 3-month average daily volume of 661.7K.

More News

Microbot Medical® Files 10-Q, Reports Significant Revenue and Customer Growth During the 2026 Second Quarter

August 11, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting

July 21, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026

July 07, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader

June 30, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System

June 25, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Announces First Health System in Pennsylvania to Adopt the LIBERTY® Endovascular Robotic System

June 23, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Enters Into an Agreement to Expand Access for America’s Veteran and Military Patient Populations

June 16, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System

June 09, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System

June 02, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System

May 26, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu

May 15, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026

May 14, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

May 05, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)

April 30, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®

April 22, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference

April 14, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting

April 13, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System

March 26, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

March 24, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® to Participate at the 38th Annual Roth Conference

March 17, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time

March 10, 2026

From Microbot Medical Inc.

Via GlobeNewswire

Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation

March 04, 2026

From Microbot Medical Inc.

Via GlobeNewswire

MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗

March 03, 2026

Via Stocktwits

Frequently Asked Questions

Is Microbot Medical Inc. - Common Stock publicly traded?

Yes, Microbot Medical Inc. - Common Stock is publicly traded.

What exchange does Microbot Medical Inc. - Common Stock trade on?

Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Microbot Medical Inc. - Common Stock?

The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market

What is the current price of Microbot Medical Inc. - Common Stock?

The current price of Microbot Medical Inc. - Common Stock is 0.9500

When was Microbot Medical Inc. - Common Stock last traded?

The last trade of Microbot Medical Inc. - Common Stock was at 10/16/26 04:00 PM ET

What is the market capitalization of Microbot Medical Inc. - Common Stock?

The market capitalization of Microbot Medical Inc. - Common Stock is 63.80M

How many shares of Microbot Medical Inc. - Common Stock are outstanding?

Microbot Medical Inc. - Common Stock has 64M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.